Home Page - Reproductive Infectious Diseases Program

The Reproductive Infectious Diseases Program is a network of health professionals, researchers and knowledge users dedicated to advancing reproductive infectious diseases care and research internationally. Through local, national and global research collaborations, the team works to address emergent knowledge gaps and provide evidence-based guidance for the prevention, treatment, and care of reproductive infectious diseases. An overview of the program and the research we do can be found here.

Latest Updates from the RID Program:

Check out the RID Program’s Newest Publication in The Lancet HIV and the UBC Faculty of Medicine Interview with Dr. Elisabeth McClymont and Dr. Deborah Money on the Publication!

A new publication describing the main results of a study on the immunogenicity and efficacy of the quadrivalent HPV vaccine in women with HIV has been recently published in The Lancet HIV! This publication is entitled “Long-term immunogenicity and efficacy of the quadrivalent human papillomavirus vaccine in women with HIV: a longitudinal cohort study” and was written in collaboration with the local RID Program investigators team and our network of national collaborators. The publication describes the results from a national longitudinal cohort study of women with HIV who were given three doses of the quadrivalent HPV vaccine and followed for up to 9 years after they were vaccinated, which is the longest study of this kind ever completed!

RID Program investigators Dr. Elisabeth McClymont and Dr. Deborah Money were also interviewed by UBC News about the historic publication and its findings!

For more information, click here to access the UBC Faculty of Medicine interview about the publication, and click here to read the publication!

New Resources Co-Developed with FNHA – Early Screening Matters!

In collaboration with First Nations Health Authority, our team has recently launched a new set of resources to promote early screening in pregnancy. To access the resources click the links below!

Support that Honours your Sacred Journey

Looking for more resources? Contact us at rid.program@ubc.ca and we will be happy to print and ship you what you need!

New RID Program Syphilis Toolkit Resource Co-Developed with a Community Advisory Committee, BCAPOP and FNHA has been Released!
The RID Program has released the Syphilis in Pregnancy Toolkit for Community and Outreach Programs. This resource was co-developed with BCAPOP, FNHA and a community advisory committee and aims to help support care of syphilis in pregnancy in BC. Read More
The RID Program 2025 Annual Report is Now Available!
The RID Program’s 2025 Annual Report is now available, which describes the remarkable work that was completed over the course of the 2025 calendar year! Read More
RID Program’s Newest Publication in JAMA Featured by Numerous Media Outlets Around the World!
The RID Program's newest publication "The Role of Vaccination in Maternal and Perinatal Outcomes Associated With COVID-19 in Pregnancy" has been featured by numerous news outlets around the world! Read More
New Publication Highlighting Results of CANCOVID-Preg Project Published in JAMA!
A new publication authored by members of the RID Program local team and national network of collaborators was just published in JAMA (The Journal of the American Medical Association)! Read More
Two New Publications for the RID Program Team!
Two new publications authored by members of the RID Program Team have been published in Microbiology Spectrum and the British Columbia Medical Journal! Read More
Congratulations to Dr. Elisabeth McClymont and Dr. Jeffrey Wong on receiving 2025 Women’s Health Research Institute Catalyst Grants!
Congratulations to RID Program Investigators Dr. Elisabeth McClymont and Dr. Jeffrey Wong on receiving 2025 Women's Health Research Institute Catalyst Grants! Read More
Dr. Deborah Money and Dr. Jeffrey Wong Give Joint Presentation at D.A. Boyes Society Meeting!
As a part of this year's D.A. Boyes meeting, RID Program Lead Dr. Deborah Money and RID Program Investigator Dr. Jeffrey Wong completed a joint presentation entitled "Reproductive Infectious Diseases Updates". Read More
New Publication: “Cost-effectiveness of infant and maternal RSV immunization strategies, in British Columbia, Canada”
A new publication authored by a team including RID Program clinician-investigator Dr. Jeffrey Wong and RID Program collaborator Dr. Pascal Lavoie was recently published in Vaccine! Read More
New Publication: “Safety of Cefazolin in Pregnant Patients with Documented Penicillin Allergy: A Retrospective Cohort Study”
A new publication authored by team of authors including RID Program investigator Dr. Chelsea Elwood was recently published in the Canadian Journal of Hospital Pharmacy! Read More
Congratulations to Dr. Julie van Schalkwyk on UBC Clinical Faculty Award!
This honor is awarded by the UBC Faculty of Medicine annually, to celebrate notable clinical faculty members who have exhibited excellence in clinical teaching in the past year. Congratulations again on this honor Dr. van Schalkwyk! Read More

Highlighted Research

NOVA-HIV

A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living with HIV

The goal of this study is to explore reduced dosing of the nonavalent HPV vaccine in women living with HIV. This multi-site phase IV clinical trial will carry on from our previous HPV in HIV studies. Recruitment began in late 2023 and is currently ongoing.

REACT-Syph

Towards the Eradication of Congenital Syphilis in Canada (REACT-Syph): Canadian Maternal and Congenital Syphilis Surveillance

In order to combat the rising rates of syphilis in pregnancy and congenital syphilis and create evidence-based prevention strategies, we need a better understanding of the circumstances surrounding infections and why diagnosis and treatment in pregnant women is not happening consistently across the country. As part of this project, we are creating a pan-Canadian syphilis in pregnancy surveillance program that includes cases from 2013-present. This surveillance system will build on established infrastructure and relationships to characterize cases of antenatal syphilis, including cases that result in congenital syphilis, identify barriers to care and gaps in current prevention strategies, and inform future interventions.

RECOVERED: Vaccine Registry for 2024 Pregnancies

Respiratory Syncytial Virus (RSV) Vaccine and Monoclonal Antibody Treatment in Canadian Pregnant Individuals and their Infants (RECOVERED): An Evaluation of Acceptability, Safety, and Efficacy

The RECOVERED Project is a Canada-wide project being conducted by the UBC Reproductive Infectious Diseases Program and is investigating Respiratory Syncytial Virus (RSV) Vaccines in pregnancy. The RECOVERED project aims to broaden our understanding of vaccine attitudes, pregnancy outcomes, and infant outcomes related to maternal vaccination and infant monoclonal antibody treatment for RSV.